BNIP3 and metabolic dysfunction-associated steatohepatitis: Loss of BNIP3 results in increased hepatic lipid synthesis, reduced AMPK activity, elevated reactive oxygen species, inflammation, and features of NASH in mice livers, suggesting that reduced mitophagy leads to NAFLD30.